Biotechnology News

April 9, 2014

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, will release its first quarter 2014 financial results on...

April 9, 2014

WASHINGTON--(BUSINESS WIRE)--BIO announced today its selection of Congressman Sam Farr (D-CA) as a Legislator of the Year. Representative Farr receives the award in conjunction with today’s BIO Legislative Day Fly-In.

April 9, 2014

PARIS--(BUSINESS WIRE)--Cegedim Relationship Management today announced the release of its thought leadership white paper, 2014 European Trends in Aggregate Spend, Transparency and Disclosure. This report analyzes the results of Cegedim’s fourth...

April 9, 2014

PARIS--(BUSINESS WIRE)--Cegedim Relationship Management today announced the release of its thought leadership white paper, 2014 European Trends in Aggregate Spend, Transparency and Disclosure. This report analyzes the results of Cegedim’s fourth...

April 9, 2014

WASHINGTON--(BUSINESS WIRE)--Biotech leader testifies at Congressional hearing on legislative proposals to enhance capital formation for small and emerging growth companies.

April 9, 2014

MUNICH--(BUSINESS WIRE)--Brainlab announced today that well over 1,000,000 patient treatments have been performed with Novalis to date.

April 9, 2014

MORRISVILLE, N.C.--(BUSINESS WIRE)--Health Canada grants SunTech Medical a Medical Device License for the Tango® M2 Non-Invasive Blood Pressure (NIBP) Monitor. This license provides cardiac stress testing labs in Canada the ability to purchase...

April 9, 2014

RAVENSBURG, Germany--(BUSINESS WIRE)--Vetter today introduced two clinical syringe packages that make it easier to start syringe development earlier in the drug development process.

April 9, 2014

MORRISVILLE, N.C.--(BUSINESS WIRE)--Clinipace Worldwide, a global digital clinical research organization (dCRO), announced today that Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company focused on the discovery and...

April 9, 2014

WINNIPEG, Manitoba--(BUSINESS WIRE)--Intelligent Hospital Systems today announced that Palmetto Health produced its first medication doses with RIVA, the only fully-automated pharmacy IV compounding system on the market today.

April 9, 2014

DALLAS--(BUSINESS WIRE)--Cerebain Biotech Corp. (“Cerebain” or “the Company”), a subsidiary of Discount Dental Materials, Inc. (OTCBB: DDOO), announced that medical device product development company, Sonos Models, Inc. (“Sonos Product...

April 9, 2014

WORCESTER, Mass.--(BUSINESS WIRE)--Agilux Laboratories, a leading provider of Drug Metabolism and Pharmacokinetics (DMPK) services to pharmaceutical and biotechnology firms, announced today that it has appointed Richard M. LeLacheur, Ph.D. to...

April 9, 2014

GAITHERSBURG, Md.--(BUSINESS WIRE)--GlycoMimetics, Inc. (NASDAQ:GLYC) announced today that three posters of preclinical research study data for its E-Selectin antagonist (GMI-1271) were highlighted at the American Association for Cancer Research...

April 9, 2014

NORCROSS, Ga.--(BUSINESS WIRE)--Guided Therapeutics’ (OTCBB: GTHP) (OTCQB: GTHP) LuViva® Honored as Finalist in the Medical Device Excellence Awards

April 9, 2014

TUCSON, Ariz.--(BUSINESS WIRE)--New era for ostomates: OstoSolutions™ is pleased to announce the issuance of patent approval for the first and only Ostomy Pouch Disposal Seal for 100% odor-free disposal of used ostomy pouches.

April 9, 2014

WASHINGTON--(BUSINESS WIRE)--BIO announced today its selection of Congresswoman Renee Ellmers (R-NC) as Legislator of the Year for 2013-2014. She received the award last night, in conjunction with BIO Legislative Day Fly-In.

April 9, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Next-Generation Gene Synthesis Company Gen9 Appoints Jennifer A. Camacho as Chief Legal and Business Counsel

April 9, 2014

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Quintiles Transnational Holdings Inc. (NYSE: Q) will release its financial results for the first quarter of 2014 prior to its quarterly earnings call on Thursday, May 1, 2014, at 8:00 a.m. EDT.

April 9, 2014

SAN DIEGO--(BUSINESS WIRE)--bioTheranostics, Inc., the leading genomic solutions provider for cancer diagnosis, has signed a contract with Prime Health Services, Inc., a national preferred provider organization network, to cover the company’s...

April 9, 2014

COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ:OSIR), the leading stem cell company focused on developing and marketing products to treat conditions in wound care, orthopedic and sports medicine markets, announced that it has...

April 9, 2014

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus reported financial results for its 2nd quarter of fiscal year 2014. Net sales were $3.081 million & gross profit $2.589 million for the Company's 26th consecutive profitable quarter.

April 9, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Spero Therapeutics partners with Roche to develop drugs for drug resistant bacterial infections

April 9, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced the presentation of scientific data at the American...

April 9, 2014

MIRAMAR BEACH, Fla.--(BUSINESS WIRE)--RBCC and n3D Seek Out Additional Capital

April 9, 2014

NEW YORK & BARCELONA, Spain--(BUSINESS WIRE)--Forest Laboratories, Inc. (NYSE:FRX) and Almirall, S.A. (ALM:MC) today announced that they have recently received feedback from the U.S. Food and Drug Administration (FDA) regarding the fixed dose...

April 9, 2014

PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Paris:IPN) (Pink Sheets IPSEY) (Euronext: IPN; ADR: IPSEY) today confirmed its eligibility for the PEA-PME scheme, in accordance with the French decree n° 2014-283 of 4 March 2014. The Group...

April 9, 2014

LYON, France--(BUSINESS WIRE)--Regulatory News: ERYTECH Pharma (Paris:ERYP) (Euronext Paris: FR0011471135 - ERYP), a French biopharmaceutical company that develops innovative treatments for acute leukemia and other oncology indications with unmet...

April 8, 2014

PRINCE WILLIAM COUNTY, Va.--(BUSINESS WIRE)--Prince William County, Virginia today welcomed ISOThrive, a start-up life sciences company, as the first tenant of the Prince William Science Accelerator.

April 8, 2014

WALTHAM, Mass. & SAN DIEGO--(BUSINESS WIRE)--ImmunoGen, Inc. (NASDAQ: IMGN), a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, today announced the first findings from...

April 8, 2014

ATLANTA--(BUSINESS WIRE)--Round2Funding invites early stage healthcare Companies to apply for their exclusive Pitch Competition to be held May 17th at the Georgia Tech Conference Center in front of several of Investors.

April 8, 2014

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that it plans to appoint Paul N. Clark and James G. Cullen to the board of directors of Keysight Technologies, Inc. Clark is expected to become Keysight’s...

April 8, 2014

AUSTIN, Texas--(BUSINESS WIRE)--Mirna Therapeutics (Mirna), a private, clinical stage biopharmaceutical company focused on the development of microRNA-based oncology therapeutics, today announced interim safety data from a multicenter, open-label...

April 8, 2014

TEANECK, N.J.--(BUSINESS WIRE)--Arxspan Introduces Service Integrating SAFE-BioPharma Digital Signatures into Any Existing Application

April 8, 2014

ROCKVILLE, Md.--(BUSINESS WIRE)--The Tech Council of Maryland praised state lawmakers for advancing key priorities for the tech community during this year’s legislative session.

April 8, 2014

PHOENIX--(BUSINESS WIRE)--Arizona’s Bioscience Roadmap, the strategic plan that has guided Arizona’s fast-growing bioscience sector for nearly 12 years, is gearing up for a new decade with updated goals and strategies.

April 8, 2014

SAN DIEGO--(BUSINESS WIRE)--NIH Center for Regenerative Medicine Founding Director Dr. Mahendra Rao joins Stemedica's Scientific and Medical Advisory Board.

April 8, 2014

SAN DIEGO--(BUSINESS WIRE)--The European Centre for Clinical Research Training (ECCRT), a SynteractHCR company, has been recognized by TransCelerate BioPharma Inc. as an official training facility meeting high standards.

April 8, 2014

WILLOW GROVE, Pa.--(BUSINESS WIRE)--NMS Labs, a premier independent provider of professional forensic and clinical laboratory services, has announced the promotion of two key individuals on its executive leadership team. William S. Hough, Jr.,...

April 8, 2014

HORSHAM, England--(BUSINESS WIRE)--Cmed has been invited to share its early phase clinical research expertise at leading industry events in the coming months.

April 8, 2014

LOS ANGELES--(BUSINESS WIRE)--HemaCare, a leading provider of cellular therapy services to healthcare providers and the scientific community, to host expert panel on cell therapy at ISCT 2014 (Paris, April 23-26).

April 8, 2014

WASHINGTON & BELO HORIZONTE, BRAZIL--(BUSINESS WIRE)--BIO and Biominas Brasil today announced that they will co-host the inaugural BIO Latin America Conference to be held September 9 through September 11, 2014 in Rio de Janeiero, Brazil.

April 8, 2014

BELGRADE, Mont.--(BUSINESS WIRE)--Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, is pleased to announce the addition of Jimmy...

April 8, 2014

BEND, Ore.--(BUSINESS WIRE)--Innovator in Solubilization Formulation Expands Board of Directors for Next Chapter of Growth, Adds Small-Cap Investment Expert

April 8, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--Corindus Vascular Robotics, a leading developer of precision vascular robotics, today announced that Tal Wenderow, Co-founder and EVP of Product & Business Development of Corindus, will present at the upcoming...

April 8, 2014

SAN CLEMENTE, Calif. & SHANGHAI--(BUSINESS WIRE)--ReFlow Medical enters into a partnership with leading Chinese medical device company

April 8, 2014

PITTSBURGH--(BUSINESS WIRE)--Positive clinical trial results of a topical botulinum toxin formulation for overactive bladder (OAB) are presented.